Reducing the Negative Effects of Surgical Conditions Use of Double Layer Mask Against Electrocautery With Smoke Filter

NCT ID: NCT06550492

Last Updated: 2024-08-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

108 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-11-01

Study Completion Date

2024-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was conducted to determine and compare the effectiveness of the smoke filtering electrocautery device used to reduce the negative effects of surgical smoke and the use of a double layer mask.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The research was conducted as a randomised controlled experimental study. The research was collected between November 2023 and February 2024 in Atatürk University Health Research and Application Centre Operating Theatre unit. Data were collected using the Personal Information Form, Specified Health Problems Questionnaire, and the Practice Record Form to record blood gas laboratory results. The study was conducted with 90 (30 control, 30 double mask, 30 device) operating theatre workers. The population of the study consisted of Atatürk University Health Practice and Research Hospital Operating Theatre unit employees between November 2023 and February 2024. In this study, a priori power analysis was performed to determine the sample size. In the power analysis, the sample of the study consisted of a total of 90 people, 30 people in the group using cautery device with smoke filtering system, 30 people in the group using double masks and 30 people in the control group, with an effect size of 0.5%, which is the medium effect size according to Cohen, an error margin level of 0.05% and a confidence interval of 0.95%, with a 95% population representativeness.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgical Procedure, Unspecified

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

experimental group using smoke filtering electrocautery device, experimental group using double mask and control group using single mask
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

experimental group using smoke filtering electrocautery device

experimental group using smoke filtering electrocautery device

Group Type EXPERIMENTAL

smoke filtering electrocautery device

Intervention Type DEVICE

A smoke-filtering electrocautery device was used during surgery.

experimental group using double mask

experimental group using double mask

Group Type EXPERIMENTAL

double mask

Intervention Type OTHER

A double-layer mask was used during the operation.

control group

group using standard methods

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

smoke filtering electrocautery device

A smoke-filtering electrocautery device was used during surgery.

Intervention Type DEVICE

double mask

A double-layer mask was used during the operation.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* people over the age of 18.
* People who agreed to participate in the study,
* who have been working in the operating theatre for at least one year.
* people who do not have chronic diseases Voluntary personnel who volunteered to co-operate were included in the study.

Exclusion Criteria

* People who did not agree to participate in the study,
* persons who have been working in the operating theatre for less than one year
* people with chronic diseases,
* people who withdrew from the study before all data were collected
* Personnel whose laboratory results could not be analysed were excluded from the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ataturk University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nurhan Bagacli

Chief Researcher

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Zeynep Karaman Özlü, Professor

Role: STUDY_DIRECTOR

[email protected]

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Atatürk University Health Application and Research Centre

Erzurum, Yakutiye, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Related Links

Access external resources that provide additional context or updates about the study.

https://dergipark.org.tr/en/pub/aktd/article/969260

Karaman Özlü Z., Uymaz Aras G., Bayrak A. (2022). Ameliyathanedeki Görünmez Tehlike: Cerrahi Duman. Arşiv Kaynak Tarama Dergisi, 31(1),10-14. doi:10.17827/aktd.969260

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AtaturkU25

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.